Publications by authors named "Thomas Permutt"

Claim this Profile
A
A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions.
Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt

Pharm Stat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Panel discussion on considerations in design and analysis.
Mark Rothmann, William Crown, Thomas A Louis, Thomas Permutt, Stephen Ruberg

Pharm Stat· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining treatment effects: A regulatory perspective.
Thomas Permutt

Clin Trials· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Treatment Effects: A Primer for Nonstatisticians.
Thomas Permutt

Clin Pharmacol Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.
Robert N Schuck, Janet Woodcock, Issam Zineh, Peter Stein, Jonathan Jarow, Thomas Permutt

Clin Pharmacol Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author's reply to comments on "A taxonomy of estimands for regulatory clinical trials with discontinuations".
Thomas Permutt

Stat Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missing data in clinical trials: control-based mean imputation and sensitivity analysis.
Devan V Mehrotra, Fang Liu, Thomas Permutt

Pharm Stat· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimmed means for symptom trials with dropouts.
Thomas Permutt, Feng Li

Pharm Stat· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on 'Estimands in clinical trials - broadening the perspective'.
Thomas Permutt

Stat Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity analysis for missing data in regulatory submissions.
Thomas Permutt

Stat Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A regulatory perspective on missing data in the aftermath of the NRC report.
Lisa M LaVange, Thomas Permutt

Stat Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A taxonomy of estimands for regulatory clinical trials with discontinuations.
Thomas Permutt

Stat Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability models and computational models for ANOVA in multicenter clinical trials.
Thomas Permutt

J Biopharm Stat· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis